An IP Australia delegate has partially revoked a Coca-Cola trade mark for a cartoon lemon acquired from Monster Energy in 2015, finding scant evidence that Hubert’s Lemonade, which features the winking lemon, has been sold in Australia.
Agricultural giant Nufarm has lost its appeal of a decision giving rival Advanta Seeds extra time to pay a renewal fee for its patent for a hybrid plant cell, after an error by its lawyers caused the renewal to fall through the cracks.
Agricultural chemical company Nufarm has appealed a decision giving rival Advanta Seeds extra time to pay a renewal fee for its patent for a hybrid plant cell after correspondence from its lawyers was sent to employees that had left the company and the patent renewal fell through the cracks.
Discount pharmacy Priceline cannot trade mark the signature bright pink that adorns it shopfront signs and awnings, an IP Australia delegate has found.
IP Australia has rejected e-commerce giant Amazon’s patent application for a method of allocating resources in virtual computers, finding the patent’s claims were “nothing more than a scheme for scheduling work” and were not a manner of manufacture.
Advanta Seeds has been denied more time to pay renewal fees for its patent for a hybrid plant cell after correspondence from its lawyers about the renewal was sent to employees that had left the company and the patent renewal fell through the cracks during a 2016 systems upgrade.
Cheese maker Saputo’s proposed trade mark for an adorable cheese cartoon figure is substantially identical to Bega’s intellectual property for a ‘smiling anthropomorphised’ cheese biped and cannot be trade marked, a delegate of the trade marks office has found.
The owner of a Melbourne-based dermatology clinic has come out on top in a battle with Johnson & Johnson over a trade mark for creams and cosmetic products.
Running a law firm is not without risk, chief among them staring down a lawsuit by a client, an ex-partner or employee, even a rival firm. Last year, Australian firms faced numerous actions alleging everything from sex discrimination to negligence.
US biotech giant Gilead has struck back at a patent infringement lawsuit brought by a specialist HIV pharmaceutical company majority owned by GlaxoSmithKline, saying the patent at the centre of the lawsuit is invalid.